The National Taiwan University Hospital is a medical facility located in the Zhongzheng District of Taipei, Taiwan. It started operations under Japanese rule in Daitōtei on 18 June 1895, and moved to its present location in 1898.

There are 2,400 beds in National Taiwan University Hospital - Hematology And Oncology.

During the past decade, National Taiwan University Hospital - Hematology And Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Taiwan University Hospital - Hematology And Oncology" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Taiwan University Hospital - Hematology And Oncology" are "Adult T Cell Leukemia/Lymphoma" (1 trials), "Advanced Malignancies" (1 trials), "Myelofibrosis" (1 trials) and "Relapsed/Refractory Peripheral T-Cell Lymphoma" (1 trials). Many other conditions were trialed in "National Taiwan University Hospital - Hematology And Oncology" in a lesser frequency.

Most popular intervention types in "National Taiwan University Hospital - Hematology And Oncology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine 1000 mg/m² PO BID" (1 trials), "PXS-5505" (1 trials), "Pamiparib 20, 40, 60 mg PO Twice Daily (BID)" (1 trials), "Pemetrexed 500 mg/m² IV" (1 trials) and "Temozolomide 120, 80, 40 or 20 mg PO Once Daily (QD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Taiwan University Hospital - Hematology And Oncology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "National Taiwan University Hospital - Hematology And Oncology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in National Taiwan University Hospital - Hematology And Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Taiwan University Hospital - Hematology And Oncology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".